UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and Tolerability of an mGlu2 3 Agonist in the Treatment of Generalized Anxiety Disorder

Neuropsychopharmacology (New York, N.Y.), 2008-06, Vol.33 (7), p.1603-1610

2008

Volltextzugriff (PDF)

Rational Design of a Combination Medication for the Treatment of Obesity

Obesity (Silver Spring, Md.), 2009-01, Vol.17 (1), p.30-39

2009

Volltextzugriff (PDF)

Comparative Effect of Atypical and Conventional Antipsychotic Drugs on Neurocognition in First-Episode Psychosis: A Randomized, Double-Blind Trial of Olanzapine Versus Low Doses of Haloperidol

The American journal of psychiatry, 2004-06, Vol.161 (6), p.985-995

2004

Volltextzugriff (PDF)

A Novel Augmentation Strategy for Treating Resistant Major Depression

The American journal of psychiatry, 2001-01, Vol.158 (1), p.131-134

2001

Volltextzugriff (PDF)

Onset of antidepressant effect of olanzapine and olanzapine/fluoxetine combination in bipolar depression

Bipolar disorders, 2007-09, Vol.9 (6), p.618-627

2007

Volltextzugriff (PDF)

Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial

European neuropsychopharmacology, 1997-05, Vol.7 (2), p.125-137

1997

Volltextzugriff (PDF)

Oral olanzapine versus oral haloperidol in the maintenance treatment of schizophrenia and related psychoses

British journal of psychiatry, 1998-06, Vol.172 (6), p.499-505

1998

Volltextzugriff (PDF)

The course of depressive symptoms in predicting relapse in schizophrenia: a double-blind, randomized comparison of olanzapine and risperidone

Biological psychiatry (1969), 1999-08, Vol.46 (3), p.365-373

1999

Volltextzugriff (PDF)

Outcome Assessment and Clinical Improvement in Panic Disorder: Evidence From a Randomized Controlled Trial of Fluoxetine and Placebo

The American journal of psychiatry, 1998-11, Vol.155 (11), p.1570-1577

1998

Volltextzugriff (PDF)

Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia

The journal of clinical psychiatry, 2001-02, Vol.62 (2), p.92-100

2001

Volltextzugriff (PDF)

Olanzapine/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistance

The journal of clinical psychiatry, 2005-10, Vol.66 (10), p.1289-1297

2005

Volltextzugriff (PDF)

The double-blind variable placebo lead-in period: results from two antidepressant clinical trials

Journal of clinical psychopharmacology, 2001-12, Vol.21 (6), p.561-568

2001

Volltextzugriff (PDF)

Time-Lapse Mapping of Cortical Changes in Schizophrenia with Different Treatments

Cerebral cortex (New York, N.Y. 1991), 2009-05, Vol.19 (5), p.1107-1123

2009

Volltextzugriff (PDF)

Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study

Current medical research and opinion, 2007-02, Vol.23 (2), p.401-416

2007

Volltextzugriff (PDF)

Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol

British journal of psychiatry, 2005-12, Vol.187 (6), p.537-543

2005

Volltextzugriff (PDF)

Assessing and interpreting treatment effects in longitudinal clinical trials with missing data

Biological psychiatry (1969), 2003-04, Vol.53 (8), p.754-760

2003

Volltextzugriff (PDF)

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

The American journal of psychiatry, 1997-04, Vol.154 (4), p.457-465

1997

Volltextzugriff (PDF)

Olanzapine Versus Placebo in the Treatment of Acute Mania

The American journal of psychiatry, 1999-05, Vol.156 (5), p.702-709

1999

Volltextzugriff (PDF)

Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone

The journal of clinical psychiatry, 2001-04, Vol.62 (4), p.231-238

2001

Volltextzugriff (PDF)

Long-Term Neurocognitive Effects of Olanzapine or Low-Dose Haloperidol in First-Episode Psychosis

Biological psychiatry (1969), 2006-01, Vol.59 (2), p.97-105

2006

Volltextzugriff (PDF)

Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine

The American journal of psychiatry, 1997-04, Vol.154 (4), p.466-474

1997

Volltextzugriff (PDF)

Synergistic Effects of Olanzapine and Other Antipsychotic Agents in Combination with Fluoxetine on Norepinephrine and Dopamine Release in Rat Prefrontal Cortex

Neuropsychopharmacology (New York, N.Y.), 2000-09, Vol.23 (3), p.250-262

2000

Volltextzugriff (PDF)

Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders

Journal of clinical psychopharmacology, 1997-10, Vol.17 (5), p.407-418

1997

Volltextzugriff (PDF)

Double-blind comparison of olanzapine versus clozapine in schizophrenic patients clinically eligible for treatment with clozapine

Biological psychiatry (1969), 2001, Vol.49 (1), p.52-63

2001

Volltextzugriff (PDF)

Olanzapine Versus Haloperidol Treatment in First-Episode Psychosis

The American journal of psychiatry, 1999-01, Vol.156 (1), p.79-87

1999

Volltextzugriff (PDF)

1 – 25 von 163

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(145)
Mit Volltextzugriff
(108)

Publikationsform

Artikel
(162)
Bücher
(1)

Sprache

Englisch
(162)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(117)
Science & Technology
(117)
Humans
(114)
Psychiatry
(106)
Biological And Medical Sciences
(82)
Medical Sciences
(82)
Female
(81)
Male
(81)
Adult
(69)
Psychology. Psychoanalysis. Psychiatry
(67)
Pharmacology. Drug Treatments
(62)
Double-Blind Method
(56)
Neuropharmacology
(52)
Psychopharmacology
(51)
Treatment Outcome
(44)
Middle Aged
(42)
Antipsychotic Agents - Therapeutic Use
(39)
Schizophrenia - Drug Therapy
(37)
Benzodiazepines
(36)
Pirenzepine - Analogs & Derivatives
(35)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Efficacy and Tolerability of an mGlu2 3 Agonist in the Treatment of Generalized Anxiety Disorder

Rational Design of a Combination Medication for the Treatment of Obesity

Comparative Effect of Atypical and Conventional Antipsychotic Drugs on Neurocognition in First-Episode Psychosis: A Randomized, Double-Blind Trial of Olanzapine Versus Low Doses of Haloperidol

A Novel Augmentation Strategy for Treating Resistant Major Depression

Onset of antidepressant effect of olanzapine and olanzapine/fluoxetine combination in bipolar depression

Olanzapine versus haloperidol: acute phase results of the international double-blind olanzapine trial

Oral olanzapine versus oral haloperidol in the maintenance treatment of schizophrenia and related psychoses

The course of depressive symptoms in predicting relapse in schizophrenia: a double-blind, randomized comparison of olanzapine and risperidone

Outcome Assessment and Clinical Improvement in Panic Disorder: Evidence From a Randomized Controlled Trial of Fluoxetine and Placebo

Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia

Olanzapine/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistance

The double-blind variable placebo lead-in period: results from two antidepressant clinical trials

Time-Lapse Mapping of Cortical Changes in Schizophrenia with Different Treatments

Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study

Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol

Assessing and interpreting treatment effects in longitudinal clinical trials with missing data

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

Olanzapine Versus Placebo in the Treatment of Acute Mania

Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone

Long-Term Neurocognitive Effects of Olanzapine or Low-Dose Haloperidol in First-Episode Psychosis

Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine

Synergistic Effects of Olanzapine and Other Antipsychotic Agents in Combination with Fluoxetine on Norepinephrine and Dopamine Release in Rat Prefrontal Cortex

Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders

Double-blind comparison of olanzapine versus clozapine in schizophrenic patients clinically eligible for treatment with clozapine

Olanzapine Versus Haloperidol Treatment in First-Episode Psychosis

Suchergebnisse filtern